Beyond Air Schedules Fiscal Year End 2026 Financial Results Conference Call and Webcast
Rhea-AI Summary
Beyond Air (NASDAQ: XAIR) will report fiscal Q4 and full-year 2026 results for the period ended March 31, 2026 on Friday, June 26, 2026. Management will host a conference call and webcast at 8:00 a.m. ET for investors.
Domestic participants can dial 1-877-407-0784, international participants 1-201-689-8560, using conference ID 13761239. A live webcast and replay will be available in the Events section of Beyond Air’s website and via a direct link.
Positive
- None.
Negative
- None.
News Market Reaction – XAIR
In the Jun 23 session, XAIR gained 14.43%, reflecting a significant positive market reaction. Argus tracked a peak move of +21.2% during that session. Our momentum scanner triggered 13 alerts that day, indicating notable trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Conferences,earnings Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jan 26 | Earnings call scheduling | Neutral | -7.5% | Announcement of Q3 2026 results date and investor conference call logistics. |
| Oct 23 | Earnings call scheduling | Neutral | +4.0% | Set Q2 2026 results release and post-close conference call timing details. |
| Jul 25 | Earnings call scheduling | Neutral | -3.6% | Announced Q1 2026 results discussion with scheduled conference call and webcast. |
| May 20 | Earnings call scheduling | Neutral | +1.5% | Outlined fiscal 2025 year-end results date and access details for investors. |
| Jan 27 | Earnings call scheduling | Neutral | -1.8% | Provided timing and access for fiscal Q3 2025 financial results call. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Scheduling earnings calls has historically led to modestly negative average moves for XAIR.
Key Terms
nitric oxide medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
GARDEN CITY, N.Y., June 22, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve patients' lives, today announced that it will report financial results for its fiscal fourth quarter and full year ended March 31, 2026 on Friday, June 26, 2026. The Company's management team is scheduled to host a conference call and webcast at 8:00 am Eastern Time (ET) the same day.
| Conference Call & Webcast | |
| Friday, June 26th @ 8:00 a.m. ET | |
| Domestic: | 1-877-407-0784 |
| International: | 1-201-689-8560 |
| Conference ID: | 13761239 |
Webcast: A webcast of the live conference call can be accessed by visiting the Events section of the Company’s website (click here) or directly (click here). An online replay will be available on the Company’s website or via the direct link an hour after the call.
About Beyond Air, Inc.
Beyond Air is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. The Company has received FDA approval and CE Mark for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. For more information, visit www.beyondair.net.
CONTACTS:
Corey Davis, Ph.D.
LifeSci Advisors, LLC
Cdavis@lifesciadvisors.com
(212) 915-2577
